Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002)
暂无分享,去创建一个
N. Tokgozoglu | I. Kahramanoglu | H. Turan | M. Arvas | A. Ayhan | D. Vatansever | S. Taşkın | F. Ortaç | Ç. Taşkıran | M. Köse | M. Naki | M. Güngör | D. Altın | E. Karabük | Ö. Takmaz
[1] A. Papadia,et al. Oncological safety and perioperative morbidity in low-risk endometrial cancer with sentinel lymph-node dissection. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] J. Persson,et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. , 2019, European journal of cancer.
[3] I. Alkatout,et al. Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany , 2019, Archives of Gynecology and Obstetrics.
[4] T. Staniscia,et al. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green , 2019, Gynecologic and Obstetric Investigation.
[5] P. Escobar,et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. , 2018, The Lancet. Oncology.
[6] Paula S Lee,et al. Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. , 2017, Gynecologic oncology.
[7] T. Gungor,et al. Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion? , 2017, International Journal of Gynecologic Cancer.
[8] K. Pavlakis,et al. Identifiable Risk Factors for Lymph Node Metastases in Grade 1 Endometrial Carcinoma , 2017, International Journal of Gynecologic Cancer.
[9] A. Fader,et al. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.
[10] G. Tulunay,et al. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue , 2017, International Journal of Gynecologic Cancer.
[11] A. Ivanova,et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. , 2017, The Lancet. Oncology.
[12] S. Temkin,et al. Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer. , 2016, Gynecologic oncology.
[13] J. Soper,et al. Endometrial Cancer and the Role of Lymphadenectomy , 2016, Obstetrical and Gynecological Survey.
[14] A. Weaver,et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. , 2016, Gynecologic oncology.
[15] A. Fader,et al. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.
[16] M. Plante,et al. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. , 2015, Gynecologic oncology.
[17] M. Goodheart,et al. Intra-operative frozen section results reliably predict final pathology in endometrial cancer. , 2014, Gynecologic oncology.
[18] J. Schorge,et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. , 2014, Gynecologic oncology.
[19] G. Tulunay,et al. Accuracy of frozen-section examination for myometrial invasion and grade in endometrial cancer. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[20] A. Mariani,et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. , 2012, Gynecologic oncology.
[21] R. Barakat,et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. , 2012, Gynecologic oncology.
[22] V. Torri,et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.
[23] M. Parmar,et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.
[24] D. Levine,et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology , 2007, International Journal of Gynecologic Cancer.
[25] M. J. Webb,et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.
[26] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.